229 related articles for article (PubMed ID: 20843314)
1. Chromogenic in situ hybridization to detect EGFR gene copy number in cell blocks from fine-needle aspirates of non small cell lung carcinomas and lung metastases from colo-rectal cancer.
Simone G; Mangia A; Malfettone A; Rubini V; Siciliano M; Di Benedetto A; Terrenato I; Novelli F; Mottolese M
J Exp Clin Cancer Res; 2010 Sep; 29(1):125. PubMed ID: 20843314
[TBL] [Abstract][Full Text] [Related]
2. Validation of chromogenic in situ hybridization for detection of EGFR copy number amplification in nonsmall cell lung carcinoma.
Sholl LM; John Iafrate A; Chou YP; Wu MT; Goan YG; Su L; Huang YT; Christiani DC; Chirieac LR
Mod Pathol; 2007 Oct; 20(10):1028-35. PubMed ID: 17673923
[TBL] [Abstract][Full Text] [Related]
3. Epidermal Growth Factor Receptor (EGFR) gene copy number (GCN) correlates with clinical activity of irinotecan-cetuximab in K-RAS wild-type colorectal cancer: a fluorescence in situ (FISH) and chromogenic in situ hybridization (CISH) analysis.
Scartozzi M; Bearzi I; Mandolesi A; Pierantoni C; Loupakis F; Zaniboni A; Negri F; Quadri A; Zorzi F; Galizia E; Berardi R; Biscotti T; Labianca R; Masi G; Falcone A; Cascinu S
BMC Cancer; 2009 Aug; 9():303. PubMed ID: 19712476
[TBL] [Abstract][Full Text] [Related]
4. EGFR expression as an ancillary tool for diagnosing lung cancer in cytology specimens.
Wei EX; Anga AA; Martin SS; Jackson JG; Nordberg ML; Herrera GA; Turbat-Herrera EA
Mod Pathol; 2007 Sep; 20(9):905-13. PubMed ID: 17643093
[TBL] [Abstract][Full Text] [Related]
5. Reliability of chromogenic in situ hybridization for epidermal growth factor receptor gene copy number detection in non-small-cell lung carcinomas: a comparison with fluorescence in situ hybridization study.
Yoo SB; Lee HJ; Park JO; Choe G; Chung DH; Seo JW; Chung JH
Lung Cancer; 2010 Mar; 67(3):301-5. PubMed ID: 19505745
[TBL] [Abstract][Full Text] [Related]
6. Comparison between epidermal growth factor receptor (EGFR) gene expression in primary non-small cell lung cancer (NSCLC) and in fine-needle aspirates from distant metastatic sites.
Bozzetti C; Tiseo M; Lagrasta C; Nizzoli R; Guazzi A; Leonardi F; Gasparro D; Spiritelli E; Rusca M; Carbognani P; Majori M; Franciosi V; Rindi G; Ardizzoni A
J Thorac Oncol; 2008 Jan; 3(1):18-22. PubMed ID: 18166836
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor (EGFR) gene copy number detection in non-small-cell lung cancer; a comparison of fluorescence in situ hybridization and chromogenic in situ hybridization.
Gallegos Ruiz MI; Floor K; Vos W; Grünberg K; Meijer GA; Rodriguez JA; Giaccone G
Histopathology; 2007 Nov; 51(5):631-7. PubMed ID: 17927584
[TBL] [Abstract][Full Text] [Related]
8. Predicting gefitinib responsiveness in lung cancer by fluorescence in situ hybridization/chromogenic in situ hybridization analysis of EGFR and HER2 in biopsy and cytology specimens.
Daniele L; Macrì L; Schena M; Dongiovanni D; Bonello L; Armando E; Ciuffreda L; Bertetto O; Bussolati G; Sapino A
Mol Cancer Ther; 2007 Apr; 6(4):1223-9. PubMed ID: 17406029
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor receptor 1 (IGF1R) gene copy number is associated with survival in operable non-small-cell lung cancer: a comparison between IGF1R fluorescent in situ hybridization, protein expression, and mRNA expression.
Dziadziuszko R; Merrick DT; Witta SE; Mendoza AD; Szostakiewicz B; Szymanowska A; Rzyman W; Dziadziuszko K; Jassem J; Bunn PA; Varella-Garcia M; Hirsch FR
J Clin Oncol; 2010 May; 28(13):2174-80. PubMed ID: 20351332
[TBL] [Abstract][Full Text] [Related]
10. EGFR mutation is a better predictor of response to tyrosine kinase inhibitors in non-small cell lung carcinoma than FISH, CISH, and immunohistochemistry.
Sholl LM; Xiao Y; Joshi V; Yeap BY; Cioffredi LA; Jackman DM; Lee C; Jänne PA; Lindeman NI
Am J Clin Pathol; 2010 Jun; 133(6):922-34. PubMed ID: 20472851
[TBL] [Abstract][Full Text] [Related]
11. Increased epidermal growth factor receptor (EGFR) gene copy number is strongly associated with EGFR mutations and adenocarcinoma in non-small cell lung cancers: a chromogenic in situ hybridization study of 182 patients.
Chang JW; Liu HP; Hsieh MH; Fang YF; Hsieh MS; Hsieh JJ; Chiu YT; Tsai HY; Chen YH; Chen YT; Hsu HY; Chen YT; Tsai SF; Chen YR; Hsi BL; Huang SF
Lung Cancer; 2008 Sep; 61(3):328-39. PubMed ID: 18304690
[TBL] [Abstract][Full Text] [Related]
12. Detection of ALK gene rearrangement in non-small cell lung cancer: a comparison of fluorescence in situ hybridization and chromogenic in situ hybridization with correlation of ALK protein expression.
Kim H; Yoo SB; Choe JY; Paik JH; Xu X; Nitta H; Zhang W; Grogan TM; Lee CT; Jheon S; Chung JH
J Thorac Oncol; 2011 Aug; 6(8):1359-66. PubMed ID: 21587085
[TBL] [Abstract][Full Text] [Related]
13. Chromogenic in situ hybridization is a reliable assay for detection of ALK rearrangements in adenocarcinomas of the lung.
Schildhaus HU; Deml KF; Schmitz K; Meiboom M; Binot E; Hauke S; Merkelbach-Bruse S; Büttner R
Mod Pathol; 2013 Nov; 26(11):1468-77. PubMed ID: 23743932
[TBL] [Abstract][Full Text] [Related]
14. Alterations of insulin-like growth factor-1 receptor gene copy number and protein expression are common in non-small cell lung cancer.
Tran TN; Selinger CI; Yu B; Ng CC; Kohonen-Corish MR; McCaughan B; Kennedy C; O'Toole SA; Cooper WA
J Clin Pathol; 2014 Nov; 67(11):985-91. PubMed ID: 25118293
[TBL] [Abstract][Full Text] [Related]
15. Silver-enhanced in situ hybridization for determination of EGFR copy number alterations in non-small cell lung cancer.
Wulf MA; Bode B; Zimmermann D; Rufibach K; Weder W; Moch H; Soltermann A; Tischler V
Am J Surg Pathol; 2012 Dec; 36(12):1801-8. PubMed ID: 23154768
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of epidermal growth factor receptor (EGFR) by chromogenic in situ hybridization (CISH) and immunohistochemistry (IHC) in archival gliomas using bright-field microscopy.
Marquez A; Wu R; Zhao J; Tao J; Shi Z
Diagn Mol Pathol; 2004 Mar; 13(1):1-8. PubMed ID: 15163002
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic features and prognostic implications of epidermal growth factor receptor (EGFR) gene copy number and protein expression in non-small cell lung cancer.
Jeon YK; Sung SW; Chung JH; Park WS; Seo JW; Kim CW; Chung DH
Lung Cancer; 2006 Dec; 54(3):387-98. PubMed ID: 17011067
[TBL] [Abstract][Full Text] [Related]
18. EGFR gene copy number heterogeneity in fine-needle aspiration cytology from breast carcinomas determined by chromogenic in situ hybridization.
Sauer T; Beraki K; Noren T; Garred O; Naess O
Diagn Cytopathol; 2005 Oct; 33(4):228-32. PubMed ID: 16138375
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis.
Hirsch FR; Varella-Garcia M; Bunn PA; Di Maria MV; Veve R; Bremmes RM; Barón AE; Zeng C; Franklin WA
J Clin Oncol; 2003 Oct; 21(20):3798-807. PubMed ID: 12953099
[TBL] [Abstract][Full Text] [Related]
20. Clonal MET Amplification as a Determinant of Tyrosine Kinase Inhibitor Resistance in Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer.
Lai GGY; Lim TH; Lim J; Liew PJR; Kwang XL; Nahar R; Aung ZW; Takano A; Lee YY; Lau DPX; Tan GS; Tan SH; Tan WL; Ang MK; Toh CK; Tan BS; Devanand A; Too CW; Gogna A; Ong BH; Koh TPT; Kanesvaran R; Ng QS; Jain A; Rajasekaran T; Yuan J; Lim TKH; Lim AST; Hillmer AM; Lim WT; Iyer NG; Tam WL; Zhai W; Tan EH; Tan DSW
J Clin Oncol; 2019 Apr; 37(11):876-884. PubMed ID: 30676858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
